Conţinutul numărului revistei |
Articolul precedent |
Articolul urmator |
![]() |
![]() ![]() |
![]() CHIRVAS, Elena, LUPAŞCO, Iulianna, DUMBRAVA, Vlada-Tatiana, HAREA, Gheorghe, GHELIMICI, Tatiana. The humoral immunological profile of patients with chronic hepatitis B infection (HBsAg-negative / anti-HBcor–positive serologic status) in association with asthma. In: Journal of Gastrointestinal and Liver Diseases, 2016, nr. S2(25), pp. 199-200. ISSN 1841-8724. |
EXPORT metadate: Google Scholar Crossref CERIF DataCite Dublin Core |
Journal of Gastrointestinal and Liver Diseases | ||||||
Numărul S2(25) / 2016 / ISSN 1841-8724 /ISSNe 1842-1121 | ||||||
|
||||||
Pag. 199-200 | ||||||
|
||||||
![]() |
||||||
Rezumat | ||||||
Introduction: Chronic hepatitis B infection (HBsAg-negative/anti-HBcor–positive serologic status) (CHBI) in association with asthma (A) is a result of the involvement of immunological mechanisms in the development of both diseases. Aim: Assessment of humoral immunological profile in patients with chronic hepatitis B infection (HBsAg-negative/anti-HBcor–positive serologic status) in association with asthma. Material, methods: The study included 66 patients. The control group (group I) comprised 10 healthy individuals. There were 39 patients with CHBI associated with A (group II), and the group with CHBI without A consisted of 27 patients (group III). Groups II and III were divided into subgroup A - with normal transaminase levels and subgroup B - with high transaminase levels. Clinical and laboratory examination was performed with assessment of biochemical data; serum markers of viral hepatitis, HBV DNA PCR; cellular and humoral immune profile; abdominal US, spirometry. Results: An increase of serum IgE was observed in group II-B 226.97±54.82 IU/ml vs. group I 78.25±38.73 IU/ml (p<0.05). The same tendency was found in group II-B vs. group III-B 74.28±27.03 IU/ml (p<0.05), as well as in group II-A 184.87±46.82 IU/ml vs. group III-A 40.49±10.16 IU/ml (p<0.01). Elevation of IgM was evidenced in group II-B 234.83±23.05mg/dL vs. group I 129.9±22.3 mg/dL(p<0.01). Statistical difference between groups was also assessed between II-B and III-B 115.25±14.4mg/dL (p<0.001). A decrease of IgA levels was detected in group III-B 179.4±18.32mg/dL and in group III-A 190.36±18.16mg/dL vs. group I 248.7±21.98 mg/dL (p<0.05). At the same time, an IgA increase was observed in group II-B 247.24±19.9mg/dL vs. group III-B 179.4±18.32mg/dL (p<0.05). Conclusions: The most significant humoral immune disorders were found in the group of patients with chronic hepatitis B infection (HBsAg-negative/anti-HBcor–positive serologic status) with high levels of transaminases in association with asthma. |
||||||
|